Enhanced delivery of lipophilic nutrients to the infant brain via high density lipoprotein.
Lipoproteins are the primary carriers of lipophilic cognitive nutrients such as docosahexaenoic acid, lutein, and α-tocopherol within circulation. The critical roles these nutrients play in growth and development are well established, and as such, their efficient delivery to the infant brain is crucial. Given the selectivity of the blood brain barrier, the lipoprotein fraction primarily responsible for brain delivery of these nutrients must be determined so that efforts aimed at increasing brain nutrient uptake, via lipoprotein profile manipulation, can be appropriately focused. Based on the preclinical and clinical data reviewed here, we hypothesize that high density lipoprotein is the fraction chiefly responsible for delivery of docosahexaenoic acid, lutein, and α-tocopherol to the infant brain. As high density lipoprotein levels tend to be lower in preterm, formula-fed infants as compared to their full-term, breast-fed counterparts, efforts aimed at increasing circulating high density lipoprotein levels, and subsequent delivery of cognitive lipophilic nutrients to the brain via manipulation of formula composition, may be most effective if targeted to this group. These efforts include (1) limiting the polyunsaturated: saturated fatty acid ratio; (2) increasing the casein: whey ratio; (3) altering the proportion of saturated fatty acids found in the sn-2 position of the parent triglyceride; (4) cholesterol supplementation; and (5) nucleotide supplementation.
Abbott Nutrition, Abbott Laboratories, Research Park at the University of Illinois at Urbana-Champaign, Champaign, IL, United States; Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, United States.
J K
JK
Naberhuis
Abbott Nutrition, Abbott Laboratories, Columbus, OH, United States. Electronic address: chron-si.lai@abbott.com.
C-S
CS
Lai
D001921:Brain / Q000378:metabolism*; D016503:Drug Delivery Systems; D006801:Humans; D007223:Infant; D008075:Lipoproteins, HDL / Q000008:administration & dosage*
D008075:Lipoproteins, HDL